Citation Impact
Citing Papers
Systemic Agonistic Anti-CD40 Treatment of Tumor-Bearing Mice Modulates Hepatic Myeloid-Suppressive Cells and Causes Immune-Mediated Liver Damage
2015
Induction of T-cell Immunity Overcomes Complete Resistance to PD-1 and CTLA-4 Blockade and Improves Survival in Pancreatic Carcinoma
2015
CD40 Agonist Antibodies in Cancer Immunotherapy
2019
The emerging landscape of novel 4-1BB (CD137) agonistic drugs for cancer immunotherapy
2023
Target-conditioned diffusion generates potent TNFR superfamily antagonists and agonists
2024 StandoutScienceNobel
A genetic method specifically delineates Th1-type Treg cells and their roles in tumor immunity
2023 StandoutNobel
Platelet factor 4–induced T H 1-T reg polarization suppresses antitumor immunity
2024 StandoutScienceNobel
Regulatory T cells in tumor microenvironment: new mechanisms, potential therapeutic strategies and future prospects
2020
Using Phage Display to Select Antibodies Recognizing Post-translational Modifications Independently of Sequence Context
2006 StandoutNobel
A proteomic atlas of senescence-associated secretomes for aging biomarker development
2020 Standout
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
Local immunotherapy based on agonistic CD40 antibodies effectively inhibits experimental bladder cancer
2014
Selective Functionalization of Tailored Nanostructures
2012 StandoutNobel
Improving de novo protein binder design with deep learning
2023 StandoutNobel
Beyond natural antibodies: the power of in vitro display technologies
2011
Antibody-based proteomics: fast-tracking molecular diagnostics in oncology
2010
Delivery technologies for cancer immunotherapy
2019 Standout
Inflammation and Colon Cancer
2010 Standout
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Direct patterning of nanoparticles and biomolecules by liquid nanodispensing
2015 StandoutNobel
Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancer
2017 StandoutNobel
Nanoscale‐Controlled Enzymatic Degradation of Poly(L ‐lactic acid) Films Using Dip‐Pen Nanolithography
2010
Polymeric microparticles for sustained and local delivery of antiCD40 and antiCTLA-4 in immunotherapy of cancer
2015
3D bioprinting of tissues and organs
2014 Standout
Graphene‐Based Materials: Synthesis, Characterization, Properties, and Applications
2011 Standout
Immunity, Inflammation, and Cancer
2010 Standout
High-Voltage Electrical Pulses in Oncology: Irreversible Electroporation, Electrochemotherapy, Gene Electrotransfer, Electrofusion, and Electroimmunotherapy
2020 Standout
mRNA vaccine with unmodified uridine induces robust type I interferon-dependent anti-tumor immunity in a melanoma model
2022 StandoutNobel
Applications of antibody array platforms
2006
High‐Contrast Photopatterning of Photoluminescence within Quantum Dot Films through Degradation of a Charge‐Transfer Quencher
2012 StandoutNobel
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
STATs in cancer inflammation and immunity: a leading role for STAT3
2009 Standout
Macrophages as regulators of tumour immunity and immunotherapy
2019 Standout
IL-6 and Stat3 Are Required for Survival of Intestinal Epithelial Cells and Development of Colitis-Associated Cancer
2009 Standout
Tumour-associated macrophages as treatment targets in oncology
2017 Standout
Coinhibitory Receptor Expression and Immune Checkpoint Blockade: Maintaining a Balance in CD8+ T Cell Responses to Chronic Viral Infections and Cancer
2017 StandoutNobel
A survey of the year 2002 commercial optical biosensor literature
2003
Targeting ferroptosis as a vulnerability in cancer
2022 Standout
STAT3 and STAT1 mediate IL-11–dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice
2008
A 3D bioprinting system to produce human-scale tissue constructs with structural integrity
2016 Standout
Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms
2013 Standout
The Immune Revolution: A Case for Priming, Not Checkpoint
2018
Revisiting STAT3 signalling in cancer: new and unexpected biological functions
2014 Standout
Topological design and additive manufacturing of porous metals for bone scaffolds and orthopaedic implants: A review
2016 Standout
Dual stimulation of antigen presenting cells using carbon nanotube-based vaccine delivery system for cancer immunotherapy
2016
International Network for Comparison of HIV Neutralization Assays: The NeutNet Report II
2012
Signal Transducer and Activator of Transcription‐3, Inflammation, and Cancer
2009 Standout
Computational design of ligand-binding proteins with high affinity and selectivity
2013 StandoutNatureNobel
Clinical relevance of tumour-associated macrophages
2022
HIV-1 Neutralization Profile and Plant-Based Recombinant Expression of Actinohivin, an Env Glycan-Specific Lectin Devoid of T-Cell Mitogenic Activity
2010 StandoutNobel
Chemically Functionalized Surface Patterning
2011
Tumour-infiltrating B cells: immunological mechanisms, clinical impact and therapeutic opportunities
2022
STAT3-Driven Upregulation of TLR2 Promotes Gastric Tumorigenesis Independent of Tumor Inflammation
2012
Electrochemical Biosensors - Sensor Principles and Architectures
2008 Standout
Agarose-Assisted Dip-Pen Nanolithography of Oligonucleotides and Proteins
2009
More than a sidekick: the IL-6 family cytokine IL-11 links inflammation to cancer
2010
TIMER2.0 for analysis of tumor-infiltrating immune cells
2020 Standout
Targeting Treg cells in cancer immunotherapy
2019 StandoutNobel
Rapid activation of tumor-associated macrophages boosts preexisting tumor immunity
2018
Matrix-binding checkpoint immunotherapies enhance antitumor efficacy and reduce adverse events
2017
Three-dimensional printing of complex biological structures by freeform reversible embedding of suspended hydrogels
2015 Standout
Self-Assembled RANK Induces Osteoclastogenesis Ligand-Independently
2005
Molecular Pathways: Activating T Cells after Cancer Cell Phagocytosis from Blockade of CD47 “Don't Eat Me” Signals
2015
Zr-based metal–organic frameworks: design, synthesis, structure, and applications
2016 Standout
In situ expansion of engineered human liver tissue in a mouse model of chronic liver disease
2017 StandoutNobel
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Redox-Activating Dip-Pen Nanolithography (RA-DPN)
2009
A Single‐Cell Assay for Time Lapse Studies of Exosome Secretion and Cell Behaviors
2016
Polymers for 3D Printing and Customized Additive Manufacturing
2017 Standout
The NMR–Rosetta capsid model of M13 bacteriophage reveals a quadrupled hydrophobic packing epitope
2015 StandoutNobel
Painting with Biomolecules at the Nanoscale: Biofunctionalization with Tunable Surface Densities
2012
Heterogeneous Catalysis of a Copper-Coated Atomic Force Microscopy Tip for Direct-Write Click Chemistry
2009 StandoutNobel
The biology , function , and biomedical applications of exosomes
2020 StandoutScience
Anatomy and Dynamics of a Supramolecular Membrane Protein Cluster
2007 StandoutScienceNobel
Radiotherapy combination opportunities leveraging immunity for the next oncology practice
2016
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Surface Plasmon Resonance Sensors for Detection of Chemical and Biological Species
2008 Standout
Continuous liquid interface production of 3D objects
2015 StandoutScience
Combination therapy strategies for improving PD‐1 blockade efficacy: a new era in cancer immunotherapy
2017 StandoutNobel
Extensive surface protein profiles of extracellular vesicles from cancer cells may provide diagnostic signatures from blood samples
2016
gp130 at the nexus of inflammation, autoimmunity, and cancer
2010
Co-Stimulatory Receptors in Cancers and Their Implications for Cancer Immunotherapy
2020
Lymphatic vessels in cancer
2022
3D Bioprinting of Vascularized, Heterogeneous Cell‐Laden Tissue Constructs
2014 Standout
CTLA-4 in Regulatory T Cells for Cancer Immunotherapy
2021
Filamentous Phage Display in the New Millennium
2005
Printing and Prototyping of Tissues and Scaffolds
2012 Science
Cancer DNA vaccines: current preclinical and clinical developments and future perspectives
2019
Works of Peter Ellmark being referenced
Locally Delivered CD40 Agonist Antibody Accumulates in Secondary Lymphoid Organs and Eradicates Experimental Disseminated Bladder Cancer
2013
The Human Agonistic CD40 Antibody ADC-1013 Eradicates Bladder Tumors and Generates T-cell–Dependent Tumor Immunity
2014
Identification of a Strongly Activating Human Anti-CD40 Antibody That Suppresses HIV Type 1 Infection
2008
Sensitivity of HIV Type 1 Primary Isolates to Human Anti-CD40 Antibody-Mediated Suppression Is Related to Coreceptor Use
2008
Tumor-directed immunotherapy can generate tumor-specific T cell responses through localized co-stimulation
2016
Multiplex detection of surface molecules on colorectal cancers
2006
Multiplexed Lipid Dip‐Pen Nanolithography on Subcellular Scales for the Templating of Functional Proteins and Cell Culture
2008
Identification of Protein Expression Signatures Associated with Helicobacter pylori Infection and Gastric Adenocarcinoma Using Recombinant Antibody Microarrays
2006
In vitro molecular evolution of antibody genes mimicking receptor revision
2002
Detection of pancreatic cancer using antibody microarray‐based serum protein profiling
2008
Pre‐assembly of the extracellular domains of CD40 is not necessary for rescue of mouse B cells from anti‐immunoglobulin M‐induced apoptosis
2003
Serum proteome profiling of metastatic breast cancer using recombinant antibody microarrays
2008
Synergistic augmentation of CD40-mediated activation of antigen-presenting cells by amphiphilic poly(γ-glutamic acid) nanoparticles
2012
The CTLA-4 x OX40 bispecific antibody ATOR-1015 induces anti-tumor effects through tumor-directed immune activation
2019
Local CTLA4 blockade effectively restrains experimental pancreatic adenocarcinoma growth in vivo
2014
First‐in‐human study with intratumoral administration of a CD40 agonistic antibody, ADC‐1013, in advanced solid malignancies
2019
The Applicability of a Cluster of Differentiation Monoclonal Antibody Microarray to the Diagnosis of Human Disease
2008
Tumor endothelial cell up-regulation of IDO1 is an immunosuppressive feed-back mechanism that reduces the response to CD40-stimulating immunotherapy
2020
Abstract A183: ATOR-1017: A 4-1BB antibody designed for superior safety/efficacy profile in cancer immunotherapy
2019
Local checkpoint inhibition of CTLA‐4 as a monotherapy or in combination with anti‐PD1 prevents the growth of murine bladder cancer
2016